Mackey JR - Search Results

1

Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.

Galmarini CM, Clarke ML, Falette N, Puisieux A, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. Int J Cancer. 2002 Feb 1;97(4):439-45. doi: 10.1002/ijc.1628. Int J Cancer. 2002. PMID: 11802204

2

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J, Perigaud C, Dumontet C. Jordheim LP, et al. Clin Cancer Res. 2004 Aug 15;10(16):5614-21. doi: 10.1158/1078-0432.CCR-04-0506. Clin Cancer Res. 2004. PMID: 15328204

3

Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

Galmarini CM, Clarke ML, Santos CL, Jordheim L, Perigaud C, Gosselin G, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. Int J Cancer. 2003 Oct 20;107(1):149-54. doi: 10.1002/ijc.11339. Int J Cancer. 2003. PMID: 12925971

4

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

Galmarini CM, Clarke ML, Jordheim L, Santos CL, Cros E, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. BMC Pharmacol. 2004 May 24;4:8. doi: 10.1186/1471-2210-4-8. BMC Pharmacol. 2004. PMID: 15157282 Free PMC article.

5

cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer.

Sève P, Mackey JR, Isaac S, Trédan O, Souquet PJ, Pérol M, Cass C, Dumontet C. Sève P, et al. Among authors: mackey jr. Lung Cancer. 2005 Sep;49(3):363-70. doi: 10.1016/j.lungcan.2005.04.008. Lung Cancer. 2005. PMID: 15923058

6

Nucleoside analogues and nucleobases in cancer treatment.

Galmarini CM, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. Lancet Oncol. 2002 Jul;3(7):415-24. doi: 10.1016/s1470-2045(02)00788-x. Lancet Oncol. 2002. PMID: 12142171 Review.

7

Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

Galmarini CM, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. Leukemia. 2001 Jun;15(6):875-90. doi: 10.1038/sj.leu.2402114. Leukemia. 2001. PMID: 11417472 Review.

8

Class III beta-tubulin expression in tumor cells predicts response and outcome in patients with non-small cell lung cancer receiving paclitaxel.

Sève P, Mackey J, Isaac S, Trédan O, Souquet PJ, Pérol M, Lai R, Voloch A, Dumontet C. Sève P, et al. Mol Cancer Ther. 2005 Dec;4(12):2001-7. doi: 10.1158/1535-7163.MCT-05-0244. Mol Cancer Ther. 2005. PMID: 16373715

9

Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, Mackey JR, Dumontet C. Galmarini CM, et al. Among authors: mackey jr. Br J Haematol. 2003 Jul;122(1):53-60. doi: 10.1046/j.1365-2141.2003.04386.x. Br J Haematol. 2003. PMID: 12823345 Free article.

10

The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.

Seve P, Sawyer M, Hanson J, Broussolle C, Dumontet C, Mackey JR. Seve P, et al. Among authors: mackey jr. Cancer. 2006 May 1;106(9):2058-66. doi: 10.1002/cncr.21833. Cancer. 2006. PMID: 16583433 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters